EC Healthcare (HKG:2138)
Hong Kong · Delayed Price · Currency is HKD 0.6200
0.00 (0.00%)
At close: Feb 13, 2026
EC Healthcare Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -191.6 | -167.19 | -18.95 | 69.65 | 197.5 | 192.87 |
Depreciation & Amortization | 598.99 | 629.19 | 623.74 | 584.85 | 430.36 | 309.86 |
Other Amortization | 1.78 | 1.78 | 1.81 | 1.89 | 2 | - |
Loss (Gain) From Sale of Assets | -266.92 | -266.92 | 1.84 | -3.64 | -19.12 | -16.78 |
Asset Writedown & Restructuring Costs | 184.29 | 184.29 | 26.38 | 5.28 | -10.8 | 2.7 |
Loss (Gain) From Sale of Investments | 26.75 | 26.75 | 24.58 | 19.09 | 11.57 | 2.89 |
Loss (Gain) on Equity Investments | 95.43 | 95.43 | -5.43 | -12.33 | 0.67 | -4.99 |
Stock-Based Compensation | 20.27 | 20.27 | 11.95 | 63.12 | 27.69 | 9.43 |
Other Operating Activities | 18.95 | 100.21 | 72.03 | 45.96 | 103.26 | 44.54 |
Change in Accounts Receivable | -9.57 | -9.57 | -46.04 | -36.32 | 51.23 | -55.27 |
Change in Inventory | -9.92 | -9.92 | -14.31 | 19.97 | -45.19 | 26.68 |
Change in Accounts Payable | -11.34 | -11.34 | -11.53 | -14.24 | -0.34 | -6.75 |
Change in Unearned Revenue | -37.63 | -37.63 | -56.14 | -59.82 | 91.14 | 125.92 |
Change in Other Net Operating Assets | 187.87 | 187.87 | 79.17 | -78.19 | -231.61 | -10.29 |
Operating Cash Flow | 607.37 | 743.24 | 689.1 | 605.28 | 608.36 | 620.81 |
Operating Cash Flow Growth | -23.44% | 7.86% | 13.85% | -0.51% | -2.00% | 7.69% |
Capital Expenditures | -57.17 | -57.17 | -161.22 | -411.01 | -260.27 | -135.87 |
Sale of Property, Plant & Equipment | 23.22 | 23.22 | 41.29 | 12.38 | 43.56 | 20.64 |
Cash Acquisitions | -43.89 | -43.89 | -96.01 | -62.11 | -286.95 | -347.99 |
Divestitures | 440.34 | 440.34 | 0.32 | - | - | 0.76 |
Sale (Purchase) of Intangibles | - | - | - | -1.48 | - | -13.23 |
Investment in Securities | -24 | -24 | -155.62 | -18.02 | -71.9 | 102.45 |
Other Investing Activities | -278.76 | 2.79 | 12.89 | -243.53 | 4.37 | 4.22 |
Investing Cash Flow | 59.73 | 341.28 | -358.36 | -723.77 | -571.19 | -369.02 |
Short-Term Debt Issued | - | - | 10 | - | - | 304.84 |
Long-Term Debt Issued | - | 112.5 | 686.64 | 494.33 | - | 304.2 |
Total Debt Issued | 112.5 | 112.5 | 696.64 | 494.33 | - | 609.04 |
Short-Term Debt Repaid | - | - | - | - | - | -279.44 |
Long-Term Debt Repaid | - | -534.43 | -823.13 | -357.12 | -555.04 | -139.53 |
Total Debt Repaid | -534.43 | -534.43 | -823.13 | -357.12 | -555.04 | -418.98 |
Net Debt Issued (Repaid) | -421.93 | -421.93 | -126.49 | 137.22 | -555.04 | 190.06 |
Issuance of Common Stock | - | - | - | 8.51 | 811.77 | 106.85 |
Common Dividends Paid | -11.85 | -11.85 | -55.69 | -118 | -271.96 | -113.86 |
Other Financing Activities | -70.62 | -200 | -304.29 | -67.84 | -84.73 | -26.27 |
Financing Cash Flow | -504.41 | -633.79 | -486.46 | -40.12 | -99.95 | 156.78 |
Foreign Exchange Rate Adjustments | -0.46 | -0.45 | -0.52 | -1.76 | 1.95 | 2.05 |
Net Cash Flow | 162.22 | 450.29 | -156.23 | -160.37 | -60.84 | 410.62 |
Free Cash Flow | 550.19 | 686.07 | 527.88 | 194.27 | 348.09 | 484.94 |
Free Cash Flow Growth | -12.96% | 29.97% | 171.73% | -44.19% | -28.22% | -4.29% |
Free Cash Flow Margin | 13.73% | 16.57% | 12.54% | 5.01% | 11.92% | 23.31% |
Free Cash Flow Per Share | 0.46 | 0.58 | 0.45 | 0.16 | 0.30 | 0.47 |
Cash Interest Paid | 78.77 | 78.77 | 91.61 | 31.15 | 24.2 | 16.94 |
Cash Income Tax Paid | 72.63 | 72.63 | 49.96 | 85.51 | 67.32 | 53.74 |
Levered Free Cash Flow | 549.77 | 558.4 | 225.53 | 439.94 | 449.14 | 401.15 |
Unlevered Free Cash Flow | 600.05 | 615.09 | 288.55 | 479.72 | 479.71 | 415.93 |
Change in Working Capital | 119.41 | 119.41 | -48.85 | -168.6 | -134.77 | 80.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.